Independent US-licensed providers· US-licensed compounding pharmacy· HIPAA-safe intake· Discreet US shipping

Last updated 2026-08-02

Start Your Intake

Begin a short intake to be evaluated by a US-licensed provider. Peptides are available after a licensed-provider evaluation. Educational content.

This page starts the process of connecting you with a US-licensed provider for an evaluation. Completing the form below does not guarantee a prescription; that decision belongs to the provider who reviews your history.

Reassurance before you begin

This takes a few minutes. Nothing here commits you to a purchase, and you can stop at any point. Your information is handled under our HIPAA Notice of Privacy Practices, and it is reviewed by a US-licensed provider within an independent network of US-licensed providers, not by Van Peptides staff directly. Individual results vary, and a provider may determine that a different medication, or no prescription at all, is the right outcome for your situation.

Medications you can request an evaluation for

Each of these is available after a licensed-provider evaluation and, if prescribed, compounded through a US-licensed compounding pharmacy.

  • Semaglutide
  • Tirzepatide
  • BPC-157
  • CJC-1295 / Ipamorelin
  • Wolverine (BPC-157 + TB-500)
  • Tesamorelin
  • GHK-Cu
  • GLOW (GHK-Cu + BPC-157 + TB-500)
  • MOTS-c

Request a provider evaluation

Submitting this form does not create a prescription or a patient–provider relationship. A US-licensed provider will follow up within one business day. Your information is handled under our HIPAA Notice of Privacy Practices.

Once your intake is received, a US-licensed provider will follow up within one business day.

What happens next

Once you submit, your intake is routed to a US-licensed provider for review. They may contact you for additional information or a brief consultation before making a clinical decision. If a prescription is appropriate, it will be compounded through a US-licensed compounding pharmacy and shipped to you; if not, the provider will explain why and discuss alternatives if any exist. See How It Works for the full process, or review our Telehealth Informed Consent before you begin.